Document:

EX-10.13

 Exhibit 10.13 

INCENTIVE UNIT AWARD AND CONTRIBUTION AGREEMENT 

THIS INCENTIVE UNIT AWARD AND CONTRIBUTION AGREEMENT (this “Unit Agreement”), effective as of the date of grant set forth on
Exhibit 1 hereto (the “Date of Grant”), is between Chloe Ox Holdings, LLC, a Delaware limited liability company (the “Chloe”), Chloe Ox Aggregator, LLC, a Delaware limited liability company (the
“Company”) and the individual whose name is set forth on Exhibit 1 hereto (the “Grantee”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Chloe LLC Agreement (as
defined below). 
 Section 1. 
 1.1.
Issuance. 
 (a) Upon execution of this Unit Agreement, Chloe will issue to Grantee and Grantee will receive from Chloe, the number of
Class B Common Units (the “Corresponding Chloe Units”) specified on Exhibit 1, subject to the terms of the Amended and Restated Limited Liability Company Agreement of Chloe, dated as of December 21, 2017 (the
“Chloe LLC Agreement”). Chloe and the Grantee agree that the “Floor Amount” as of the Date of Grant, as such term is used herein and in the Chloe LLC Agreement, is $0.00, which shall result in the Vested Portion being
entitled to Distributions pursuant to Section 4.1(b) of the Chloe LLC Agreement in accordance with the terms thereof upon satisfaction of the Distribution obligations set forth in Section 4.1(a) of the Chloe LLC Agreement. 

(b) Immediately following the issuance of the Corresponding Chloe Units described in Section 1.1(a) above, Grantee shall contribute,
transfer and assign to the Company and the Company shall accept, acquire and assume from Grantee, all right, title and interest in and to the Corresponding Chloe Units in exchange for the incentive units (the “Incentive Units”)
specified on Exhibit 1, without any pecuniary consideration paid, or any other Capital Contribution made or deemed made, by or on behalf of Grantee in respect thereof, subject to the provisions of the Amended and Restated Limited Liability
Company Agreement of the Company, dated as of December 21, 2017 (the “LLC Agreement”). 
 (c) The Corresponding Chloe
Units and Incentive Units will be subject to the vesting conditions set forth in Section 2 herein. 
 1.2. Characterization as
Profits Interests. The parties intend to characterize the Corresponding Chloe Units and the Incentive Units issued hereunder as “profits interests” within the meaning of Revenue Procedures 93-27 (1993-2 C.B. 343) and 2001-43 (2001-2 C.B. 191). Prior to or after the issuance of the Corresponding Chloe Units and the Incentive
Units pursuant to this Unit Agreement, the Grantee and Chloe shall each execute and deliver to the Internal Revenue Service (the “IRS”) an election under Section 83(b) of the Code in the form attached hereto as Exhibit 2
with respect to the Corresponding Chloe Units and Grantee shall execute and deliver to the IRS an election under Section 83(b) of the Code in the form attached hereto as Exhibit 2 with respect to the Incentive Units (together the
“83(b) Elections”) on a protective basis. The Grantee understands that under Section 83(b) of the Code, regulations promulgated thereunder, and certain IRS administrative announcements, in the absence of an effective

 
election under Section 83(b) of the Code, the excess of the Fair Market Value of any Corresponding Chloe Units or Incentive Units, on the date on which any forfeiture restrictions applicable
to such Corresponding Chloe Units or Incentive Units lapse, over the price paid for such Corresponding Chloe Units or Incentive Units, could be reportable as ordinary income at that time. For this purpose, the term “forfeiture
restrictions” includes the restrictions on transferability and the vesting and reversion conditions imposed under Section 2. The Grantee understands that (i) in making the 83(b) Elections, the Grantee may be taxed at the time the
Corresponding Chloe Units and Incentive Units are received hereunder to the extent the Fair Market Value of the Corresponding Chloe Units or Incentive Units exceeds the price for such Corresponding Chloe Units or Incentive Units and (ii) in
order to be effective, the 83(b) Elections must be filed with the IRS within thirty (30) days after the Date of Grant. The Grantee hereby acknowledges that: (x) the foregoing description of the tax consequences of the 83(b) Elections is
not intended to be complete and, among other things, does not describe state, local or foreign income and other tax consequences; (y) none of the Company, Chloe, NM Members, any of their respective Affiliates or any of their respective
partners, members, equityholders, directors, officers, employees, agents or representatives (each, a “Related Person”) has provided or is providing the Grantee with tax advice regarding the 83(b) Elections or any other matter, and
the Company, Chloe and the NM Members and their respective Affiliates have urged the Grantee to consult the Grantee’s own tax advisor with respect to income taxation consequences of receiving, holding and disposing of the Corresponding Chloe
Units and the Incentive Units; and (z) none of the Company, Chloe, NM Members or any other Related Person has advised the Grantee to rely on any determination by it or its representatives as to the Fair Market Value specified in the 83(b)
Elections and will have no liability to the Grantee if the actual Fair Market Value of the Corresponding Chloe Units or the Incentive Units on the date hereof exceeds the amount specified in the respective 83(b) Elections. 

1.3. Adjustments. If there shall occur any change with respect to the outstanding Corresponding Chloe Units or the Incentive Units by
reason of any recapitalization, reclassification, split, reverse split or any merger, reorganization, consolidation, combination, spin-off or other similar change affecting the Corresponding Chloe Units or the
Incentive Units, Chloe or the Company may, in the manner and to the extent that it deems appropriate and equitable in its good faith discretion as reasonably exercised, cause an adjustment to be made in the number of Corresponding Chloe Unit or
Incentive Units granted hereunder, the Floor Amount and any other terms hereunder that are affected by the event to prevent dilution or enlargement of Grantee’s rights and obligations hereunder; provided, that no action may be taken by Chloe or
the Company pursuant to this Section 1.2 which will have a material adverse effect on the Corresponding Chloe Units or the Incentive Units without the prior written consent of Grantee. 

1.4. No Certificates. The Corresponding Chloe Units and Incentive Units shall be uncertificated unless otherwise determined by Chloe, in
the case of the Corresponding Chloe Units, or the Company, in the case of the Incentive Units. 

  
 - 2 - 

 Section 2. Vesting. 

2.1. Time-Based Vesting. 

(a) General. Fifty percent (50%) of the Corresponding Chloe Units and Incentive Units shall be subject to time-based vesting conditions
(together the “Time-Based Units”), subject to Sections 2.1(b), 2.1(c), and 4, and the other applicable provisions of this Unit Agreement, such Time-Based Units shall vest in the following installments and as of the following
specified vesting dates, provided that the Grantee has not been Terminated prior to the applicable vesting date: 
  

					
	 Time-Based Incentive Units Vesting Date
	  	Percentage of Time-Based Units Vesting	 
	 December 31, 2018
	  	 	25	% 
	 December 31, 2019
	  	 	25	% 
	 December 31, 2020
	  	 	25	% 
	 December 31, 2021
	  	 	25	% 

 Except as provided in Section 2.1(c) below, there shall be no proportionate or partial vesting in the periods prior to
each vesting date set forth above and all vesting shall occur only on the applicable vesting date, subject to the Grantee’s continued service with Chloe or any of its Subsidiaries through each applicable vesting date. 

(b) Performance Criteria. Notwithstanding the provisions of Section 2.1(a) hereof, except as otherwise proved in clause (i) of
Section 2.1(c) below, if the Grantee fails to achieve the requirements set forth in the performance criteria attached hereto as Exhibit 3 (the “Performance Criteria”) prior to December 31, 2019, all of the
Time-Based Units, shall, without any further action on the part or any party, shall automatically be cancelled and forfeited. 
 (c)
Accelerated Vesting of Time-Based Incentive Units. Notwithstanding the provisions of Section 2.1(a) hereof, all Time-Based Units shall become fully vested upon the occurrence of a Company Sale, provided that, (i) in the case of a
Company Sale preceding December 31, 2019, the Grantee has not been Terminated prior to such Company Sale, or (ii) in the case of a Company Sale following December 31, 2019, the Grantee satisfied the Performance Criteria prior to
December 31, 2019 and the Grantee has not been Terminated prior to such Company Sale. 
 2.2. Performance Vesting. 

(a) General. Fifty percent (50%) of the Corresponding Chloe Units and Incentive Units shall be subject to performance-based vesting
conditions (together the “Performance-Based Units”) and, subject to Section 4 and the other applicable provisions of this Unit Agreement, such Performance-Based Units shall vest based on the level of aggregate Cash-on-Cash Return achieved by the NM Members (and/or, without duplication, their direct and indirect parent entities) in accordance with the following schedule, provided
that the Grantee has not been Terminated prior to the date the applicable Cash-on-Cash Return is achieved: 

  
 - 3 - 

					
	
Cash-on-Cash
Return
	  	Percentage of Vesting of
Performance-Based Incentive Units	 
	 Less than 2.00 times
	  	 	0.00	% 
	 2.00 times
	  	 	33.33	% 
	 2.50 times
	  	 	50.00	% 
	 3.00 times
	  	 	66.67	% 
	 3.50 times
	  	 	83.34	% 
	 4.00 times or greater
	  	 	100.00	% 

 Notwithstanding the foregoing, the Performance-Based Units shall vest upon the consummation of a Company Sale in accordance
with the schedule above (with the remaining unvested portion of the Performance-Based Units, if any, being cancelled and forfeited as of the Company Sale, without any further action on the part of the parties). 

There shall be no proportionate or partial vesting for levels of achievement of Cash-on Cash Return between the
performance thresholds set forth in the table above, and all vesting shall occur on a cliff basis only to the extent that an applicable performance threshold is achieved, subject to the Grantee’s continued service with Chloe or any of its
Subsidiaries through the achievement of the Cash-on-Cash Return. The Compensation Committee shall in good faith make all determinations necessary or appropriate to
determine whether the Performance-Based Units shall have become vested and exercisable. The Compensation Committee’s determinations shall be final, binding and conclusive upon all parties, absent manifest error or bad faith. 

(b) Service Requirement. Subject to Grantee’s continued service to Chloe or any of its Subsidiaries, the Performance-Based Units
will be eligible to vest until the date of Termination. 
 2.3. Compensation Committee Discretion. Notwithstanding the foregoing, the
Compensation Committee may, in its sole discretion, provide for accelerated vesting of any portion of the Corresponding Chloe Units at any time and for any reason, which shall automatically result in the accelerated vesting of such correlative
portion of the Incentive Units. 
 2.4. Definitions. 

(a) “Cash-on-Cash Return” shall mean, without
duplication, the aggregate gross cash return realized, and/or the fair market value of marketable securities received, by the NM Members or their respective direct or indirect parent entities, as applicable, on their aggregate investment in the
equity securities of Chloe (including (x) any cash dividend, (y) distribution, (z) the proceeds of any partial liquidation of Chloe; but excluding (i) any fees or expense reimbursements under any applicable management or
professional services agreement and (ii) any fees and expenses realized in connection with any Company Sale). Deferred Consideration shall be included in
Cash-on-Cash Return if, when and to the extent actually received by the NM 

  
 - 4 - 

 
Members or, without duplication, their respective direct or indirect parent entities, as applicable. If the NM Members or, without duplication, their respective direct or indirect parent
entities, as applicable, receive non-marketable securities or other non-cash property pursuant to a distribution or as proceeds from their aggregate investment in equity
securities of Chloe, Grantee shall be treated no less favorably than any other member of the Board of Directors of Chloe (the “Board”) or officer of Chloe and its Affiliates who holds Incentive Units with respect to the inclusion or
exclusion of non-marketable securities or other non-cash property from Cash-on-Cash
Return. 
 (b) “Retention Agreement” means that certain Retention and Severance Agreement by and between Grantee, Chloe and
the Company dated September 27, 2018, as amended by that certain Relocation Letter, dated December 20, 2018, between Grantee, Chloe, the Company and Signify Health, LLC. 

(c) “Managing Member” shall have the meaning set forth in Section 3.1(c) of the LLC Agreement. 

2.5. Deferred Consideration. In connection with a Company Sale, if any portion of the transaction consideration to be received by
equityholders of Chloe is subject to any contingency or future event including, without limitation, transaction escrow arrangement, holdback, installment arrangements or earnouts (“Deferred Consideration”) is received by
equityholders of Chloe in connection with a Company Sale, a portion of the proceeds (representing the incremental dollars to be distributed under Chloe’s distribution waterfall then in effect) to be received by the Grantee in respect of the
Incentive Units may be made subject to such deferral arrangement on the same basis as the transaction consideration to be received by such equityholders is made subject to such arrangement (taking into account any applicable requirements under
Section 409A of the Code). 
 2.6. Vested Portion. Unless the context clearly requires otherwise, the term “Vested
Portion” shall refer to, (i) in the case of the Time-Based Units, the portion of the Time- Based Units which, as of a determination date, have become vested as described in Section 2.1 and, subject to the terms and conditions of
this Unit Agreement, continue to remain vested as of such date, and (ii) in the case of the Performance-Based Units, the portion of the Performance- Based Units which, as of a determination date, have become vested as described in
Section 2.2, which, for the avoidance of doubt includes only Performance-Based Units for which a Company Sale has occurred and where the applicable performance conditions have been satisfied, and, subject to the terms and conditions of this
Unit Agreement, continue to remain vested as of such date. 
 Section 3. LLC Agreement and Other Requirements; Company Call Rights. 

3.1. LLC Agreement and Other Requirements. 

(a) In General. If Grantee is not already a party to the LLC Agreement, then Grantee agrees that upon execution of this Unit Agreement,
the Grantee agrees to join and become a party to the LLC Agreement and be fully bound by, and subject to all of the covenants, terms and conditions of the LLC Agreement as though an original party thereto and the Company agrees to accept Grantee as
a party to the LLC Agreement and that this Unit Agreement shall serve as Grantee’s joinder to the LLC Agreement. 

  
 - 5 - 

 (b) Transferability of Incentive Units. The Grantee may not offer or Transfer or
agree to offer or Transfer, grant any call option with respect to, borrow against, or enter into any swap or derivative transaction with respect to any Incentive Unit or any interest therein, unless such action is taken in accordance with the LLC
Agreement or the Chloe LLC Agreement. Any attempted or purported Transfer or other agreement in violation of this Unit Agreement will be void ab initio. 

(c) Rights as a Member. The Grantee will be the record owner of each Incentive Unit until or unless such Incentive Unit reverts to the
Company as provided in Section 3.2 or is Transferred in accordance with the terms of this Unit Agreement and the LLC Agreement, and as record owner will be entitled to all rights granted to owners of Class B Common Units. 

(d) Power of Attorney. By virtue of the grant of the Incentive Units hereunder and Grantee’s execution of this Unit Agreement,
Grantee shall be deemed to have granted a power of attorney to the Managing Member in accordance with Section 9.7 of the LLC Agreement with respect to all Incentive Units owned by Grantee and acquired by Grantee hereunder, which power of
attorney shall, for the avoidance of doubt, include a grant by the Grantee of a perpetual and irrevocable power of attorney to the Company, with full right, power and authority to take all actions necessary and/or desirable on behalf of the Grantee
to effectuate the provisions of this Section 3. 
 3.2. Company Call Rights. 

(a) Except as otherwise provided in this Unit Agreement and as otherwise provided herein, in the event of the Grantee’s Termination for
any reason, the Company may repurchase from the Grantee and/or, as applicable, any of his or her Permitted Transferees the Vested Portion of each Incentive Unit based on the Fair Market Value of an Incentive Unit on the date of repurchase. For
purposes of this Section 3.2, all requirements of a Grantee shall apply equally in full force and effect with respect to any Permitted Transferee. 

(b) The Company shall have a period of one hundred eighty (180) days (or such longer period as may be necessary to avoid changing the
accounting treatment for the acquisition of the Incentive Units being repurchased from an equity-based accounting treatment to a liability based accounting treatment (as contemplated by FASB ASC Topic 718)); provided that such period shall
not exceed three hundred sixty-five (365) days) following the date of the Grantee’s Termination, in which to give notice in writing to the Grantee of the Company’s election to exercise its repurchase rights hereunder and thirty
(30) days after delivery of such notice to pay the repurchase price and consummate the repurchase transaction. For the sake of clarity, the Company may elect to repurchase any of the Incentive Units of the Grantee and/or, as applicable, any of
his or her Permitted Transferees in one or more separate transactions, it being understood that the Company may not repurchase any of the Incentive Units held by the Grantee after the last date provided for herein. The repurchase price, if any,
payable pursuant to the Company’s exercise of its repurchase rights hereunder shall be paid (i) by delivery to the Grantee of wire transfer or a certified bank check or checks in the appropriate amount payable to the order of the

  
 - 6 - 

 
Grantee; (ii) by the cancellation of any indebtedness owed by the Grantee to the Company or any of its Subsidiaries; or (iii) any combination of clauses (i) or (ii) of this
Section 3.2(b), as determined in the sole discretion of the Board of Directors of the Company. The Company may choose to have a designee purchase any Incentive Units elected by it to be purchased hereunder so long as the Company shall bear any
reasonable costs and expenses of the Grantee in connection with the sale to such designee that the Grantee would not have otherwise incurred in connection with a sale to the Company. All references to the Company in this Section 3 shall refer
to such designee as the context requires. The Grantee agrees to take all necessary and reasonable actions as directed by the Company in connection with the consummation of a repurchase pursuant to this Section 3.2, including executing the
applicable repurchase documentation. Without limiting the generality of the foregoing, the Company shall be entitled to receive customary representations and warranties from the Grantee regarding the Incentive Units being repurchased including, but
not limited to, the representation that the Grantee has good and marketable title to the Incentive Units to be repurchased free and clear of all liens, claims and other encumbrances. 

(c) In the event that (i) any Incentive Units are repurchased by the Company pursuant to the LLC Agreement, (ii) a Company Sale is
subsequently consummated during the six month period following any such repurchase transaction, and (iii) the consideration that could reasonably be expected to have been received in respect of the Incentive Units in connection with the Company
Sale (including any Deferred Consideration) is higher than the amount paid in the repurchase transaction, then at the consummation of the Company Sale the Company shall pay Grantee an amount equal to such excess (provided, however, that any payments
in respect of any Deferred Consideration will be paid to Grantee if and when received by the Company or its equity holders but in all events consistent with Section 409A of the Code). 

Section 4. Termination. 
 4.1. In
General. If the Grantee’s employment or service relationship Terminates (other than in the case of a Termination for Cause), irrespective of whether the Grantee receives, in connection with such Termination, any severance or other payment
from Chloe under any employment or service agreement or otherwise, the Incentive Units, other than the Vested Portion of the Incentive Units, shall terminate and be of no further force and effect as of and following the close of business on the date
of such Termination, unless otherwise provided for in Section 2.1(b) or Section 2.2(a). 
 4.2. Termination for Cause.
Notwithstanding anything in this Unit Agreement to the contrary, and in addition to the rights of the Company set forth in this Section 4 (or any other right the Company may have), the Incentive Units, including the Vested Portion of the
Incentive Units, shall immediately be forfeited and cancelled, without any consideration being paid therefore and without further action by the Company or any other Person, upon a Termination of the Grantee by Chloe or a subsidiary of Chloe for
Cause. 
 4.3. Certain Defined Terms. For purposes of this Unit Agreement: 

(a) “Cause” has the meaning given such term in the Retention Agreement. 

  
 - 7 - 

 (b) “Termination”, “Terminated” or
“Terminates” shall mean, with respect to the Grantee, a Termination of Employment or Service, as applicable. 
 (c)
“Termination of Employment or Service” means: a termination of employment or service (for reasons other than a military or personal leave of absence granted by Chloe) of the Grantee from Chloe and its Affiliates. Notwithstanding the
foregoing, if no rights of the Grantee are reduced or adversely affected, the Compensation Committee may otherwise define Termination of Employment or Service thereafter, provided that any such change to the definition of the term “Termination
of Employment or Service” does not subject the applicable Incentive Units or Corresponding Chloe Units to Section 409A. 
 Section 5.
Prohibited Activities. The Grantee hereby acknowledges and agrees that he or she will be subject to the restrictive covenants set forth in Exhibit 4 and incorporated herein by reference. 

Section 6. Miscellaneous. 
 6.1.
Acknowledgments. 
 (a) The Grantee hereby acknowledges receipt of a copy of this Unit Agreement and agrees to be bound by all the
terms and provisions hereof as the same may be amended from time to time. The Grantee hereby acknowledges that the Grantee has reviewed this Unit Agreement and understands the Grantee’s rights and obligations hereunder. 

(b) Except as expressly set forth in the LLC Agreement or as required by applicable law, Chloe and the Company shall have no duty or obligation
to disclose to the Grantee, and the Grantee shall have no right to be advised of, any material information regarding Chloe, the Company or any of their respective Subsidiaries at any time prior to, upon or in connection with the repurchase of
Incentive Units upon the termination of the Grantee’s employment with Chloe and/or any of its Subsidiaries or as otherwise provided hereunder; except Grantee shall be entitled to the calculation of Fair Market Value in connection with any
repurchase of the Incentive Units. 
 6.2. Resolution of Disputes. Any dispute or disagreement which may arise under, or as a result
of, or which may in any way relate to, the interpretation, or construction or of this Unit Agreement shall be determined by the Compensation Committee, in good faith, whose determination in good faith shall be final, binding and conclusive for all
purposes. 
 6.3. Grantee Representations. The Grantee shall be deemed to acknowledge and make the following representations and
warranties and as otherwise may be requested by Chloe or the Company for compliance with applicable laws, and any issuances of Incentive Units by the Company and any issuance of Corresponding Chloe Units by Chloe hereunder shall be made in reliance
upon the express representations and warranties of the Grantee: 
 (a) The execution, delivery and performance by the Grantee of this Unit
Agreement and the consummation of the transactions contemplated hereby do not and will not (with or without the giving of notice, the lapse of time, or both) result in a violation or breach of, conflict with, cause increased liability or fees, or
require approval, consent or authorization under (i) any applicable law, rule or regulation or (ii) any contract or agreement to which the Grantee is a party or by which the Grantee or any of Grantee’s properties or assets may be bound or
affected. 

  
 - 8 - 

 (b) The Grantee has all requisite legal capacity and authority to carry out the transactions
contemplated by this Unit Agreement, the LLC Agreement and the Chloe LLC Agreement. 
 (c) The Incentive Units and Corresponding Chloe Units
must be held indefinitely and Grantee must continue to bear the economic risk of the investment in the Incentive Units and the Corresponding Chloe Units unless the offer and sale of such Incentive Units and Corresponding Chloe Units are subsequently
registered under the Securities Act and all applicable state security laws or an exemption from such registration available (or otherwise provided in the LLC Agreement and the Chloe LLC Agreement). 

(d) The Grantee is acquiring and will hold the Incentive Units to be issued hereunder for investment for the Grantee’s account only and
not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act or other applicable securities laws. 

(e) The Grantee has been advised that the Incentive Units and the Corresponding Chloe Units to be issued hereunder have not been registered
under the Securities Act or other applicable securities laws, on the ground that no distribution or public offering of such Incentive Units or Corresponding Chloe Units is to be effected (it being understood, however, that such Incentive Units and
Corresponding Chloe Units are being issued and sold in reliance on an exemption from registration under the Securities Act and applicable securities laws). In connection with the foregoing, Chloe and the Company are relying in part on the
Grantee’s representations set forth in this Section 6.3. The Grantee further acknowledges and understands that the Company and Chloe are under no obligation hereunder to register the Incentive Units or the Corresponding Chloe Units to be
issued hereunder. 
 (f) The Grantee is aware of the adoption of Rule 144 by the United States Securities and Exchange Commission under the
Securities Act, which permits limited public resales of securities acquired in a non-public offering, subject to the satisfaction of certain conditions. The Grantee acknowledges that the Grantee is familiar
with the conditions for resale set forth in Rule 144, and acknowledges and understands that the conditions for resale set forth in Rule 144 have not been satisfied and that the Company and Chloe have no plans to satisfy these conditions in the
foreseeable future. 
 (g) The Grantee will not Transfer the Incentive Units in violation of this Unit Agreement, the LLC Agreement, the
Securities Act (or the rules and regulations promulgated thereunder) or under any other applicable securities laws; provided that, the foregoing shall in no way limit the Grantee’s ability to Transfer the Incentive Units pursuant to the
provisions of the LLC Agreement. The Grantee agrees that the Grantee will not Transfer the Incentive Units to be issued hereunder unless and until the Grantee has complied with all requirements of this Unit Agreement, or the LLC Agreement applicable
to the disposition of such Incentive Units. 

  
 - 9 - 

 (h) The Grantee has had the opportunity to ask questions and receive answers from the
Company and Chloe concerning the terms and conditions of the issuance of the Incentive Units and Corresponding Chloe Units and to obtain any additional information which the Company or Chloe possesses or can acquire without unreasonable effort or
expense that the Grantee has requested. 
 (i) The Grantee is an “accredited investor” as defined in Rule 501(a)(6) of Regulation D
of the Securities Act as the result of having (i) individual income in excess of $200,000 in each of 2016 and 2017, or joint income with Grantee’s spouse in excess of $300,000 in each of 2016 and 2017, and (ii) a reasonable
expectation of having individual income in excess of $200,000 in 2018, or joint income with Grantee’s spouse in excess of $300,000 in 2018. 

(j) The Grantee is an experienced and sophisticated investor and has such knowledge and experience in financial and business matters as are
necessary to evaluate the merits and risks of an investment in the Incentive Units and the Corresponding Chloe Units. The Grantee is aware that the Incentive Units and the Corresponding Chloe Units are a speculative investment that has limited
liquidity and is subject to the risk of complete loss. The Grantee is able, without impairing the Grantee’s financial condition, to hold the Incentive Units and the Corresponding Chloe Units to be issued hereunder for an indefinite period and
to suffer a complete loss of the Grantee’s investment in such Incentive Units and Corresponding Chloe Units. 
 (k) The Grantee has only
relied on the advice of, or has consulted with, the Grantee’s own legal, financial and tax advisors, and the determination of the Grantee to acquire the Incentive Units and the Corresponding Chloe Units pursuant to this Unit Agreement has been
made by the Grantee independent of any statements or opinions as to the advisability of such acquisition or as to the properties, business, prospects or condition (financial or otherwise) of Chloe, the Company or any of their respective Subsidiaries
which may have been made or given by any other Person (including all Persons acquiring Incentive Units on the date hereof) or by any agent or employee of such Person and independent of the fact that any other Person has decided to become a holder of
Incentive Units. 
 6.4. Governing Law; Venue; Service of Process; Waiver of Jury Trials. 

(a) This Unit Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, without giving effect to any
choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Any dispute relating hereto shall be
heard in the state or federal courts of Delaware, and the parties agree to jurisdiction and venue therein (it being understood and agreed that any order from any such court may be enforced in any other jurisdiction). Each of the parties hereto
hereby waives, to the fullest extent permitted by law, any right to trial by jury of any claim, demand, action, or cause of action (i) arising under this Unit Agreement or (ii) in any way connected with or related or incidental to the
dealings of the parties hereto in respect of this Unit Agreement or any of the transactions contemplated hereby, in each case whether now existing or hereafter arising, and whether in contract, tort, equity, or otherwise. The parties hereto each
hereby agrees and consents that any such claim, demand, action, or cause of action shall be decided by court trial without a jury and that the parties hereto may file an original counterpart of a copy of this Unit Agreement with any court as written
evidence of the consent of the parties hereto to the waiver of their right to trial by jury. 

  
 - 10 - 

 (b) The Grantee (i) agrees that service of process in any such any claim, demand,
action, proceeding or cause of action arising under this Unit Agreement may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party, in the case of the
Grantee, at the Grantee’s address shown in the books and records of the Company or Chloe, in the case of the Company, at the Company’s principal offices, attention General Counsel, or in the case of Chloe, at Chloe’s principal
offices, attention General Counsel, and (ii) agrees that nothing in this Unit Agreement shall affect the right to effect service of process in any other manner permitted by the laws of the State of Delaware. 

6.5. Specific Performance. Each of the parties agrees that any breach of the terms of this Unit Agreement will result in irreparable
injury and damage to the other parties, for which there is no adequate remedy at law. Each of the parties therefore agrees that in the event of a breach or any threat of breach, the other parties shall be entitled to an immediate injunction and
restraining order to prevent such breach, threatened breach or continued breach, and/or compelling specific performance of this Unit Agreement, without having to prove the inadequacy of money damages as a remedy or balancing the equities between the
parties. Such remedies shall be in addition to any other remedies (including monetary damages) to which the other parties may be entitled at law or in equity. Each party hereby waives any requirement for the securing or posting of any bond in
connection with any such equitable remedy. 
 6.6. Severability. Whenever possible, each provision of this Unit Agreement shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Unit Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Unit Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision
had never been contained herein. 
 6.7. Notice. Unless otherwise provided herein, all notices, requests, demands, claims and other
communications to be given or delivered under or by reason of the provisions of this Unit Agreement shall be in writing and shall be deemed to have been duly received (a) upon receipt by hand delivery, (b) upon receipt after being mailed
by certified or registered mail, postage prepaid, (c) the next business day after being sent via a nationally recognized overnight courier, or (d) upon confirmation of delivery if transmitted by electronic mail electronic mail in portable
document format (PDF format) with an electronic read receipt requested, to the email address indicated (provided a copy thereof is also sent by one of the other methods described in this Section 6.7. Such notices, demands and other
communications shall be sent to the address, email address or facsimile number indicated below: 

  
 - 11 - 

 (a) If to the Company and Chloe: 

Chloe Ox Holdings, LLC 
 c/o New
Mountain Capital, L.L.C. 
 787 Seventh Avenue 

New York, NY 10019 
 Attention:
Vignesh Aier and Nikhil Devulapalli 
 E-mail: 

(b) If to the Grantee, at the most recent address or electronic mail address contained in the Company’s or Chloe’s records. 

6.8. Binding Effect; Assignment. This Unit Agreement shall be binding on all successors and permitted assigns of the Grantee, including,
without limitation, the estate of such Grantee and the executor, administrator or trustee of such estate. 
 6.9. Amendments and
Waivers. The Board shall have the right to amend the Agreement with the consent of the Grantee and the Managing Member; provided, however, that to the extent necessary under any applicable law, regulation, or exchange requirement, no amendment
shall be effective unless approved by the members of the Company if required by applicable law, regulation, or exchange requirement. 
 6.10.
Counterparts. This Unit Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same instrument. 

6.11. Entire Agreement. This Unit Agreement, the LLC Agreement (together with any documents contemplated hereby or thereby) and the
Chloe LLC Agreement (together with any documents contemplated hereby or thereby) constitute the entire agreement between the parties, and supersedes and replaces all prior agreements and understandings, oral and written, between the parties hereto
with respect to the subject matter hereof; provided, however, that nothing herein will supersede, amend or replace the Retention Agreement or that certain Incentive Unit Award and Contribution Agreement, dated as of May 3, 2018,
between Grantee, Chloe and the Company. 
 6.12. Transfer of Personal Data. The Grantee authorizes, agrees and unambiguously consents
to the transmission by Chloe or the Company (or any Subsidiary of Chloe or the Company) of any personal data information related to the Incentive Units or the Corresponding Chloe Units awarded under this Unit Agreement for legitimate business
purposes. This authorization and consent is freely given by the Grantee. 
 6.13. No Right to Continued Employment or Business
Relationship. This Unit Agreement shall not confer upon the Grantee any right with respect to continued employment or a continued business relationship with Chloe, the Company or any Affiliate thereof, nor shall it interfere in any way with the
right of Chloe, the Company, or any Affiliate thereof to Terminate the Grantee at any time. 

  
 - 12 - 

 6.14. Compliance with Laws. The issuance of the Incentive Units and the Corresponding
Chloe Units pursuant to this Unit Agreement shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations and any other law or regulation applicable thereto.
The Company and Chloe shall not be obligated to issue the Incentive Units or the Corresponding Chloe Units if any such issuance would violate any such requirements. As a condition to the issuance of the Incentive Units and the Corresponding Chloe
Units, the Company and Chloe may require the Grantee to satisfy any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation. 

6.15. Delivery by Email. This Unit Agreement, the agreements referred to herein, and each other agreement or instrument entered into in
connection herewith or therewith or contemplated hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of email with a scan attachment, shall be treated in all manner and respects as an original
agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in Person. No party hereto or to any such agreement or instrument shall raise the use of email to
deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of email as a defense to the formation or enforceability of a contract, and each such party forever waives any such
defense. 
 6.16. Further Assurances. The Grantee shall, and shall cause its Affiliates to, from time to time, furnish Chloe and the
Company such further information or assurances, execute and deliver such additional documents, instruments and conveyances, and take such other actions and do such other things, as may be reasonably necessary to carry out the provisions of this Unit
Agreement and give effect to the transactions contemplated hereby. 
 6.17. General Interpretive Principles. Whenever used in this
Unit Agreement, except as otherwise expressly provided or unless the context otherwise requires, any noun or pronoun shall be deemed to include the plural as well as the singular and to cover all genders. The headings of the sections, paragraphs,
subparagraphs, clauses and subclauses of this Unit Agreement are for convenience of reference only and shall not in any way affect the meaning or interpretation of any of the provisions hereof. Unless otherwise specified, the terms
“hereof,” “herein” and similar terms refer to this Unit Agreement as a whole (including the exhibits, schedules and disclosure statements hereto), and references herein to Sections refer to Sections of this Unit Agreement. Words
of inclusion shall not be construed as terms of limitation herein, so that references to “include,” “includes” and “including” shall not be limiting and shall be regarded as references to
non-exclusive and non-characterizing illustrations. 

[Signature pages follow] 

  
 - 13 - 

 IN WITNESS WHEREOF, the parties hereto have executed this Unit Agreement, effective as of
the Date of Grant. 
  

			
	Chloe Ox Holdings, LLC
		
	By:	 	 /s/ Bradford Kyle Armbrester

		 	Name:  Bradford Kyle Armbrester
		 	Title:  Chief Executive Officer

  

			
	Chloe Ox Aggregator, LLC
		
	By:	 	 /s/ Vignesh Aier

		 	Name:  Vignesh Aier
		 	Title:  President and Secretary

 [Signature Page to Unit Agreement] 

	
	 Agreed and acknowledged as
 of the Date of
Grant:

	
	 /s/ David Clarence Deinlein Pierre

	Grantee: David Clarence Deinlein Pierre

  
 [Signature Page to Unit
Agreement] 

 Exhibit 1 

 

			
	 Grantee’s Name:
	  	David Clarence Deinlein Pierre
	 Date of Grant:
	  	December 20, 2018
	 Corresponding Chloe Units:
	  	10,000
	 Incentive Units:
	  	10,000
	 Time-Based Units:
	  	5,000
	 Performance-Based Units:
	  	5,000

 Exhibit 2 

ELECTION TO INCLUDE AMOUNT 

IN GROSS INCOME PURSUANT TO 

SECTION 83(b) OF THE INTERNAL REVENUE CODE 

On December 20, 2018, the undersigned acquired 10,000 Class B Common Units (the “Incentive Units”) of Chloe Ox
Aggregator, LLC, a Delaware limited liability company (the “Company”) for $0.00 per Incentive Unit. The total amount paid by the undersigned for the Incentive Units was $0.00. The Incentive Units are subject to a substantial risk of
forfeiture (described below) that may not be avoided by a transfer of the Incentive Units to another person and are also subject to certain restrictions on transfer. 

The undersigned desires to make an election to have the receipt of the Incentive Units taxed under the provisions of Code §83(b) at the
time the undersigned acquired the Incentive Units. 
 Therefore, pursuant to Code §83(b) and Treasury Regulation §1.83-2 promulgated thereunder, the undersigned hereby makes an election, with respect to the Incentive Units (described below), to report as taxable income for calendar year 2018 the excess (if any) of the
Incentive Units’ fair market value on December 20, 2018 over the purchase price thereof. 
 The following information is supplied
in accordance with Treasury Regulation §1.83-2(e): 
  

	1.	 The name, address and social security number of the undersigned: 

 

			
	                      Name:	  	David Clarence Deinlein Pierre
		
	                      Address:	  	[____________]
		
		  	[____________]
		
	                      SSN:	  	[____________]

  

	2.	 A description of the property with respect to which the election is being made: 10,000 Class B Common
Units of the Company. 

  

	3.	 The date on which the Incentive Units were transferred: December 20, 2018. The taxable year for which such
election is made: 2018. 

  

	4.	 The restrictions to which the property is subject: Under certain circumstances, the Incentive Units may be
forfeited or repurchased from the undersigned at a price equal to the lower of fair market value (as determined by the board of directors of the Company) or the original value of the Incentive Units. 

	5.	 The fair market value on December 20, 2018 of the property with respect to which the election is being
made, determined in accordance with IRS Revenue Procedure 93-27 and without regard to any lapse restrictions: $0.00 per Incentive Unit. 

 

	6.	 The amount paid or to be paid for such property: $0.00 per Incentive Unit. 

*         *        
*        *        * 

 A copy of this election has been furnished to the Company pursuant to Treasury Regulations §1.83-2(d). 
 Dated: _______________, 2018 

 

	
	  
 David Clarence Deinlein
Pierre

 ELECTION TO INCLUDE AMOUNT 

IN GROSS INCOME PURSUANT TO 

SECTION 83(b) OF THE INTERNAL REVENUE CODE 

On December 20, 2018, the undersigned acquired 10,000 Class B Common Units (the “Incentive Units”) of Chloe Ox
Holdings, LLC, a Delaware limited liability company (the “Company”) for $0.00 per Incentive Unit. The total amount paid by the undersigned for the Incentive Units was $0.00. The Incentive Units are subject to a substantial risk of
forfeiture (described below) that may not be avoided by a transfer of the Incentive Units to another person and are also subject to certain restrictions on transfer. 

The undersigned desires to make an election to have the receipt of the Incentive Units taxed under the provisions of Code §83(b) at the
time the undersigned acquired the Incentive Units. 
 Therefore, pursuant to Code §83(b) and Treasury Regulation §1.83-2 promulgated thereunder, the undersigned hereby makes an election, with respect to the Incentive Units (described below), to report as taxable income for calendar year 2018 the excess (if any) of the
Incentive Units’ fair market value on December 20, 2018 over the purchase price thereof. 
 The following information is supplied
in accordance with Treasury Regulation §1.83-2(e): 
  

	1.	 The name, address and social security number of the undersigned: 

 

			
	                      Name:	  	David Clarence Deinlein Pierre
		
	                      Address:	  	[____________]
		
		  	[____________]
		
	                      SSN:	  	[____________]

  

	2.	 A description of the property with respect to which the election is being made: 10,000 Class B Common
Units of the Company. 

  

	3.	 The date on which the Incentive Units were transferred: December 20, 2018. The taxable year for which such
election is made: 2018. 

  

	4.	 The restrictions to which the property is subject: Under certain circumstances, the Incentive Units may be
forfeited or repurchased from the undersigned at a price equal to the lower of fair market value (as determined by the board of directors of the Company) or the original value of the Incentive Units. 

 

	5.	 The fair market value on December 20, 2018 of the property with respect to which the election is being
made, determined in accordance with IRS Revenue Procedure 93-27 and without regard to any lapse restrictions: $0.00 per Incentive Unit. 

	6.	 The amount paid or to be paid for such property: $0.00 per Incentive Unit. 

*         *        
*        *        * 

 A copy of this election has been furnished to the Company pursuant to Treasury Regulations §1.83-2(d). 
 Dated: _________________, 2018 

 

	
	  
 David Clarence Deinlein
Pierre

 Exhibit 3 

Performance Criteria 
  

					
	 Zone
	 	 Metric
	 	 Time-Based Units at Risk

	Network Management	 	Network Capacity	 	1250
	Planning and Delivery	 	Completed Evaluations	 	1250
	Ancillary Services	 	Completed Tests	 	1250
	Clinical Operations	 	Coding and CDI DSOs	 	1250

 Exhibit 4 

Restrictive Covenants 
 1.
Non-Competition; Non-Solicitation. 
 (a) During the
course of Grantee’s employment with, or service to, Chloe or any of its Subsidiaries (the “Employment Term”) and for a period of twelve (12) months following the date on which Grantee ceases to be employed by or provide
services to Chloe or any of its Subsidiaries (the “Restricted Period”), Grantee agrees not to, and shall cause Grantee’s Affiliates not to, either alone or in conjunction with Grantee’s Affiliates, directly or indirectly
own, manage, operate, control, be employed by (whether as an employee, consultant, independent contractor or otherwise, and whether or not for compensation) or render services to any Person, in whatever form, engaged in the business of furnishing or
providing home health assessments and delivering care management services to patients in their homes (the “Restricted Business”) in the United States. Notwithstanding the foregoing, Grantee may directly or indirectly own, solely as
an investment, securities of any Person traded on any national securities exchange, provided that Grantee is not a controlling Person of, or a member of a group which controls, such Person and does not, directly or indirectly, own five percent (5%)
or more of any class of securities of such Person. 
 (b) During the Restricted Period Grantee agrees not to, and shall cause Grantee’s
Affiliates not to, either alone or in conjunction with Grantee’s Affiliates, directly or indirectly induce or attempt to induce any C-level executive officer of Chloe or any of its Subsidiaries (each, a
“Senior Restricted Employee”) or any employee of Chloe or any of its Subsidiaries that is not a Senior Restricted Employee (each, a “Restricted Employee”) to leave the employ or service of Chloe or any of its
Subsidiaries, hire any Senior Restricted Employee or Restricted Employee, or in any way interfere with the employee relationship between Chloe or any of its Subsidiaries and any such Senior Restricted Employee or Restricted Employee. 

(c) During the Employment Term and the Restricted Period, Grantee shall not, and shall cause Grantee’s Affiliates not to, either alone or
in conjunction with Grantee’s Affiliates, directly or indirectly, (i) solicit or service, or assist in soliciting or servicing the business of any then current client or prospective supplier, licensee, licensor or other business relation
of Chloe or any of its Subsidiaries in a manner which (x) induces such Person to cease doing business with, or (y) reduces the amount of business conducted with, Chloe or its Subsidiaries, or (ii) in any way interferes with the
relationship between any then current or prospective client, supplier, licensee, licensor or other business relation of Chloe or any of its Subsidiaries: (A) with whom Grantee had personal contact or dealings on behalf of Chloe or any of its
Subsidiaries during the one-year period immediately preceding Grantee’s termination of employment; (B) about whom Grantee had knowledge of any of Chloe’s or any of its Subsidiaries’ plans
with respect to such Person; (C) with whom employees reporting to Grantee have had personal contact or dealings on behalf of Chloe or any of its Subsidiaries during the one-year period immediately
preceding Grantee’s termination of employment; or (D) for whom Grantee had direct or indirect responsibility during the one-year period immediately preceding Grantee’s termination of employment.

 (d) Grantee acknowledges and agrees that the length of the covenants set forth in this
Section 1 are reasonable and narrowly drawn to impose no greater restraint than is necessary to protect the goodwill of Chloe and its respective Subsidiaries. 

2. Confidentiality; Intellectual Property. 

(a) Confidentiality. 
 (i)
Grantee will not at any time, whether during or after the Employment Term, (A) retain or use for the benefit, purposes or account of Grantee or any other Person; or (B) disclose, divulge, reveal, communicate, share, transfer or provide
access to any Person outside of Chloe, its Subsidiaries or its Affiliates (other than Grantee’s professional advisers who are bound by confidentiality obligations or otherwise in performance of Grantee’s duties during Grantee’s
employment and/or service with Chloe and/or its Affiliates and/or Subsidiaries and pursuant to customary industry practice), any non-public, proprietary or confidential information, including, without
limitation, trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual property, information concerning finances,
investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions, government and regulatory activities and approvals,
in each case, concerning the past, current or future business, activities and operations of Chloe or its Affiliates or Subsidiaries and/or any third party that has disclosed or provided any of same to Chloe or any of its Subsidiaries or Affiliates
on a confidential basis (“Confidential Information”), without the prior written authorization of the Board. 
 (ii)
“Confidential Information” shall not include any information that is (A) generally known to the industry or the public other than as a result of Grantee’s breach of this or any other confidentiality covenant; (B) made
legitimately available to Grantee by a third party without breach of any confidentiality obligation of which Grantee has knowledge; or (C) required by law to be disclosed; provided that with respect to subsection (C), Grantee shall give
prompt written notice to Chloe of such requirement, disclose no more information than is so required, and reasonably cooperate with any attempts by Chloe to obtain a protective order or similar treatment. 

(iii) Except as required by law, Grantee will not disclose to anyone, other than Grantee’s family (it being understood that, in this
Exhibit 4, the term “family” refers to Grantee, Grantee’s spouse, children, parents and spouse’s parents) and advisors, the existence or contents of this Unit Agreement; provided that Grantee may disclose to any
prospective future employer the provisions of this Exhibit 4. This Section 2(a)(iii) shall terminate if Chloe publicly discloses a copy of this Unit Agreement (or, if Chloe publicly discloses summaries or excerpts of this Unit Agreement,
to the extent so disclosed). 
 (iv) Upon termination of the Employment Term for any or no reason, Grantee shall (A) cease and not
thereafter commence use of any Confidential Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned or used by
Chloe or any of its Subsidiaries; and (B) immediately destroy, delete, or return to Chloe, at Chloe’s option, 

 
all originals and copies in any form or medium (including memoranda, books, papers, plans, computer files, letters and other data) in Grantee’s possession or control (including any of the
foregoing stored or located in Grantee’s office, home, laptop or other computer, whether or not Chloe property) that contain Confidential Information, except that Grantee may retain only those portions of any personal notes, notebooks and
diaries that do not contain any Confidential Information. 
 (v) 18 U.S.C. § 1833(b) provides: “An individual shall not be held
criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an
attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing
in this Exhibit 4 is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Unit Agreement have the
right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade
secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. 

(b) Intellectual Property. 

(i) If Grantee creates, invents, designs, develops, contributes to or improves any works of authorship, inventions, intellectual property,
materials, documents or other work product (including without limitation, research, reports, software, databases, systems, applications, presentations, textual works, content, or audiovisual materials) (“Works”), either alone or
with one or more third parties, at any time during Grantee’s Employment Term and within the scope of such employment and/or service with the use of any resources of Chloe or its Subsidiaries (collectively, “Chloe Works”),
Grantee shall promptly and fully disclose same to Chloe and hereby irrevocably assigns, transfers and conveys, to the maximum extent permitted by applicable law, all of Grantee’s right, title, and interest therein (including rights under
patent, industrial property, copyright, trademark, trade secret, unfair competition, other intellectual property laws, and related laws) to Chloe to the extent ownership of any such rights does not vest originally in Chloe. If Grantee creates any
written records (in the form of notes, sketches, drawings, or any other tangible form or media) of any Chloe Works, Grantee will keep and maintain same. The records will be available to and remain the sole property and intellectual property of Chloe
at all times. 
 (ii) Grantee shall take all requested actions and execute all requested documents (including any licenses or assignments
required by a government contract) at Chloe’s expense (but without further remuneration) to assist Chloe in validating, maintaining, protecting, enforcing, perfecting, recording, patenting or registering any of Chloe’s rights in the Chloe
Works. 

 (iii) Grantee shall not improperly use for the benefit of, bring to any premises of,
divulge, disclose, communicate, reveal, transfer or provide access to, or share with Chloe or its Subsidiaries any confidential, proprietary or non-public information or intellectual property relating to a
former employer or other third party without the prior written permission of such third party. Grantee shall comply with all relevant policies and guidelines of Chloe and its Subsidiaries that are from time to time previously disclosed to Grantee,
including regarding the protection of Confidential Information and intellectual property and potential conflicts of interest. 
 (iv) The
provisions of Section 2 hereof shall survive the termination of Grantee’s Employment Term for any or no reason. 
 3.
Whistleblower Protection. Notwithstanding anything to the contrary contained in this Unit Agreement (including Exhibit 4), no provision of this Unit Agreement shall be interpreted so as to impede Grantee (or any other individual) from
reporting possible violations of federal law or regulation to any governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or
making other disclosures under the whistleblower provisions of federal law or regulation. Grantee does not need the prior authorization of Chloe or its Subsidiaries to make any such reports or disclosures, and Grantee shall not be required to notify
Chloe or its Subsidiaries that such reports or disclosures have been made. 
 4. Other Remedies. In the event of a violation by
Grantee of this Exhibit 4, any severance being paid to Grantee pursuant to this Unit Agreement, the Retention Agreement or otherwise shall immediately cease, and any severance previously paid to Grantee shall be immediately repaid to Chloe or
its Subsidiaries. 
 5. Return of Property. Upon Termination of Grantee’s employment with Chloe or its Subsidiaries for any
reason whatsoever, voluntarily or involuntarily (and in all events within five (5) days of Grantee’s date of Termination), and at any earlier time Chloe requests, Grantee will deliver to the person designated by Chloe all originals and
copies of all documents and property of Chloe or its Subsidiaries in Grantee’s possession, under Grantee’s control or to which Grantee may have access, including but not limited to, any office or communications equipment (e.g., laptop,
cellular phone, etc.) that Grantee has or has been using, and any business or business-related files that Grantee has in Grantee’s possession. Grantee will not reproduce or appropriate for Grantee’s own use, or for the use of others, any
property or Confidential Information, and shall remove from any personal computing or communications equipment all information relating to Chloe and its Subsidiaries. 

6. Cooperation. During the Employment Term and thereafter, Grantee shall cooperate with Chloe, its Subsidiaries and Affiliates, upon
reasonable request by Chloe, with respect to any internal investigation or administrative, regulatory or judicial proceeding involving matters within the scope of Grantee’s duties and responsibilities to Chloe and its Subsidiaries (including,
without limitation, Grantee being available to Chloe upon reasonable notice for interviews and factual investigations, appearing at Chloe’s reasonable request to give testimony without requiring service of a subpoena or other legal process, and
turning over to Chloe all relevant Chloe documents which are or may come into Grantee’s possession during the Employment Term) (collectively, the “Claims”). Grantee agrees to promptly inform Chloe if Grantee becomes aware of
any lawsuits involving Claims that may be filed or threatened against 

 
Chloe or any of its Subsidiaries or Affiliates. Grantee also agrees to promptly inform Chloe (to the extent that Grantee is legally permitted to do so) if Grantee is asked to assist in any
investigation of Chloe or any of its Subsidiaries or Affiliates (or their respective actions) or another party attempts to obtain information or documents from Grantee (other than in connection with any litigation or other proceeding in which
Grantee is a party-in-opposition) with respect to matters Grantee believes in good faith to relate to any investigation of Chloe or its Subsidiaries or Affiliates, in
each case, regardless of whether a lawsuit or other proceeding has then been filed against Chloe or its Subsidiaries or Affiliates with respect to such investigation, and shall not do so unless legally required. During the pendency of any litigation
or other proceeding involving Claims, Grantee shall not communicate with anyone (other than Grantee’s attorneys and tax and/or financial advisors and except to the extent that Grantee determines in good faith is necessary in connection with the
performance of Grantee’s duties hereunder) with respect to the facts or subject matter of any pending or potential litigation or regulatory or administrative proceeding involving Chloe or its Subsidiaries or Affiliates without giving prior
written notice to Chloe or its counsel. Upon presentation of appropriate documentation, Chloe shall pay or reimburse Grantee for all reasonable out-of-pocket travel,
duplicating or telephonic expenses incurred by Grantee in complying with this paragraph. 
 7. Tolling. In the event of any violation
of the provisions of this Exhibit 4, Grantee acknowledges and agrees that the post-termination restrictions contained in this Exhibit 4 shall be extended by a period of time equal to the period of such violation, it being the intention
of the parties hereto that the running of the applicable post-termination restriction period shall be tolled during any period of such violation.EX-10.17

 Exhibit 10.17 

EMPLOYMENT AGREEMENT 

EMPLOYMENT AGREEMENT (this “Agreement”), is entered into as of May 15, 2020 (the “Effective
Date”) by and between Cure TopCo, LLC, a Delaware limited liability company (the “Company”), and David Pierre (the “Executive” and, together with the Company, the “Parties” and each a
“Party”). 
 RECITALS 

WHEREAS, the Parties desire to enter into this Agreement to set forth the terms, provisions and conditions of the Executive’s
employment with the Company; 
 WHEREAS, the Company desires to employ the Executive pursuant to the terms, provisions and
conditions; 
 WHEREAS, the Executive desires to be employed by the Company on the terms, provisions and conditions hereinafter set
forth in this Agreement; and 
 WHEREAS, the Executive acknowledges that (i) the Executive’s employment with the Company
will provide the Executive with trade secrets of, and confidential information concerning the Company, its subsidiaries and its affiliates; and (ii) the covenants contained in this Agreement are essential to protect the business and goodwill of
the Company, its subsidiaries and its affiliates. 
 NOW, THEREFORE, in consideration of the premises and of the mutual promises and
covenants contained herein, the Parties, intending to be legally bound, hereby agree as follows: 
 1. Employment 

(a) Term. Subject to earlier termination in accordance with Section 3 of this Agreement, Executive shall be
employed by the Company for an initial term commencing on the Effective Date and ending on December 31, 2021 (the “Initial Term”); provided, that the Initial Term shall automatically renew for successive one year terms thereafter
(each a “Renewal Term,” and together with the Initial Term, the “Term”) unless, no later than sixty (60) days prior to the expiration of the Initial Term, or any Renewal Term, the Company or Executive provides
written notice to the other party of his/its desire not to extend the Term (a “Non-Renewal). Upon Executive’s termination of employment with the Company for any reason, Executive shall immediately
resign from any and all positions with the Company Group, including any position on the Company’s board of directors (the “Board”) and/or any other position as an officer or director of any subsidiary of the Company.
Notwithstanding anything set forth herein to the contrary, if Company does not renew the Term of this Agreement except for Cause as defined below in Section 3(c), it shall be treated as a termination Without Cause and Executive shall be
entitled to all of the payments and benefits set forth in Section 3 (d) below. 

  
 1 

 (b) Position. During the Term, Executive shall serve as the Company’s Chief
Operating Officer. If requested by the Board or the Chief Executive Officer, Executive shall serve as a member of the Board and/or as an officer or director of any subsidiary of the Company, in each case without additional compensation. 

(c) Duties. As the Chief Operating Officer, the Executive shall perform those duties and responsibilities on behalf of the Company as
are required of persons in such a position, and such additional executive duties and responsibilities as may be assigned to the Executive from time to time by the Board or the Chief Executive Officer of the Company 

(d) Best Efforts/Exclusivity. 

(i) During the Term, the Executive shall devote the Executive’s full business time and best efforts, business judgment, skill and
knowledge exclusively to the advancement of the business and interests of Company and its subsidiaries and to the discharge of the Executive’s duties and responsibilities for the Company and its subsidiaries. The Executive shall not engage in
any activity that conflicts or interferes with the Executive’s duties and responsibilities hereunder. 
 (ii) The Executive agrees that
the Executive will not knowingly take any action prejudicial to the Company, its subsidiaries or their respective interests. The Executive acknowledges and understands that the Executive shall not be authorized to enter, and is hereby prohibited
from entering, into any contractual arrangement other than in accordance with applicable Company policies, or in cases where policies do not exist, as afforded to the Executive by Executive’s position. The Executive represents that the
execution of this Agreement, and the performance of the Executive’s obligations hereunder, do not and will not violate or conflict with the provisions of any other agreement to which the Executive is a party or to which the Executive is bound.

 2. Compensation and Benefits. 
 (a)
Base Salary. During the Term, the Company shall pay the Executive a salary at the annual rate of no less than $360,000 (such salary, as the same may be increased, but not decreased, from time to time, is referred to as the “Base
Salary”), payable in accordance with the payroll practices of the Company. The Executive’s Base Salary shall be subject to annual review by the Board (or committee thereof). 

(b) Annual Bonus Opportunity. During the Term and subject to the achievement of the applicable annual performance goals, Executive shall
be eligible to earn an annual bonus, with a target amount equal to $360,000 which amount shall, at the sole discretion of the Company, be subject to review and adjustment on an annual basis (the “Target Bonus”), with the
understanding that the range of any bonus shall be between 0% and 200% of the Target Bonus as determined by the Board (or a committee thereof) in its sole discretion (the “Annual Bonus”). The Annual Bonus, if any, shall be paid to
the Executive on a date selected by the Company in the calendar year following the calendar year in which the Annual Bonus relates, but not later than thirty (30) days following the date on which the Board approves the Company’s audited
financial statements for the calendar year to which the Annual Bonus relates, subject to Executive’s continued employment with the Company or any of its subsidiaries through the date of payment (except as provided in
Section 3(b)(ii) below). The Annual Bonus is not an accrued right under this Agreement. 

  
 2 

 (c) Employee Benefits. During the Term, subject to the Executive’s payment of
any contribution required of executive employees generally, the Executive will be eligible to participate under this Agreement in any and all employee benefit plans and perquisite and fringe benefits programs made generally available to other
executive employees of Company, as in effect from time to time, except to the extent such plans are duplicative of a category of benefits otherwise provided to the Executive under this Agreement. It is understood by Executive that the terms of such
plans may change from time to time, at the sole discretion of the Company. Such participation by the Executive shall be subject to: (i) the terms and conditions of the applicable plan documents; (ii) generally applicable policies of
Company; and (iii) the discretion of the Board or any administrative or other committee provided for in or contemplated by such plan. 

(d) Expense Reimbursement. During the Term, the Company shall reimburse the Executive, in accordance with the policies and practices of
the Company in effect from time to time, for all reasonable business expenses and other disbursements incurred by the Executive for or on behalf of the Company in connection with the performance of the Executive’s duties hereunder, including
expenses for travel and airfare as are customary for the other senior executives of the Company, entertainment, lodging and similar items, upon presentation by the Executive to the Company of appropriate documentation thereof in accordance with the
policies and practices of the Company in effect from time to time. The amount of expenses eligible for reimbursement during any calendar year shall not affect the expenses eligible for reimbursement in any other calendar year, and the reimbursement
of an eligible expense shall be made as soon as practicable after the Executive submits the request for reimbursement, but not later than December 31 following the calendar year in which the expense is incurred. The Executive’s right to
reimbursement is not subject to liquidation or exchange for another benefit. 
 3. Termination of Employment. 

(a) General. The Executive’s employment shall terminate upon the earliest to occur of (i) the Executive’s death,
(ii) a termination by reason of a Disability (as defined below), (iii) a termination by the Company with or without Cause (as defined below), and (iv) a termination by the Executive with or without Good Reason (as defined below). 

(b) Death or Disability. The Executive’s employment shall terminate automatically upon the Executive’s death. The Company may
terminate the Executive’s employment immediately upon the occurrence of a Disability, such termination to be effective upon the Executive’s receipt of written notice of such termination. In the event the Executive’s employment is
terminated due to the Executive’s death or Disability, the Executive or the Executive’s estate or the Executive’s beneficiaries, as the case may be, shall be entitled to: (i) all accrued but unpaid Base Salary through the date of
termination of the Executive’s employment hereunder; (ii) to the extent earned, and if not yet paid, the Annual Bonus for the previous calendar year (the “Prior Year’s Bonus”); (iii) any unpaid or unreimbursed
expenses incurred in accordance with Company policy, including amounts due under Section 2(d) hereof to the extent incurred prior to termination of employment; and (iv) any benefits provided under the Company’s
employee benefit plans, in accordance with the terms therein (items (i) through (v) collectively, the “Accrued Obligations”). 

  
 3 

 For purposes of this Agreement, “Disability” shall mean any physical or
mental disability or infirmity that has at the time of termination already rendered the Executive incapable, with reasonable accommodation, of performing the Executive’s usual and customary duties as set forth herein for a period of one hundred
twenty (120) days during any twelve (12) month period. Any question as to the existence or extent of Executive’s Disability upon which Executive and the Company cannot agree shall be determined by a qualified, independent physician
selected by the Company and approved by the Executive or the Executive’s representatives (which approval shall not be unreasonably withheld or delayed). 

Except as set forth in this Section 3(b), following the Executive’s termination of employment by reason of death
or Disability, the Executive shall have no further rights to any compensation or benefits under this Agreement. 
 (c) Termination by the
Company for Cause. The Company may terminate the Executive’s employment hereunder at any time for Cause upon written notice to the Executive. Such written notice shall specify in reasonable detail the particular act or acts or failure or
failures to act that constitute the grounds on which the proposed termination for Cause is based. For purposes of this Agreement, “Cause” shall mean: (i) the Executive’s conviction of, or a plea of guilty or nolo
contendere to, a (A) felony or (B) any crime of moral turpitude; (ii) the Executive’s embezzlement, a breach of fiduciary duty or fraud with regard to the Company or any of its assets or businesses; (iii) the
Executive’s continued failure to perform the duties of the Executive’s position (other than as a result of a Disability), in the Board’s reasonable judgment; (iv) the Executive’s dishonesty, willful misconduct, or illegal
conduct relating to the affairs of the Company or any of its affiliates or customers; (v) the Executive’s breach of a material provision of this Agreement or any other contractual obligation to the Company or any of its affiliated
entities; or (vi) other conduct by the Executive that may be harmful to the business, interests, or reputation of Company, including any material violation of Company policy. With respect to clauses (iii), (v) and (vi) above, the Company
shall provide ten (10) days written notice to the Executive of its intent to terminate for Cause, and during such ten (10) day period the Executive shall have a right to cure (if curable). If not cured within such period (as determined in
the Board’s reasonable judgment), the termination of Executive’s employment will be effective upon the date immediately following the expiration of the ten (10) day notice period. Notwithstanding anything to the contrary contained
herein, the Executive’s right to cure as set forth in this Section 3(c) shall not apply if there are habitual or repeated breaches by the Executive. 

If the Company terminates the Executive’s employment for Cause, the Executive shall be entitled only to the Accrued Obligations other than
the Prior Year’s Bonus. Following such termination of the Executive’s employment for Cause, except as set forth in this Section 3(c), the Executive shall have no further rights to any compensation or any other
benefits under this Agreement. 
 (d) Termination by the Company without Cause. The Company may terminate the Executive’s
employment at any time without Cause. In the event Executive’s employment is terminated by the Company without Cause (other than due to death or Disability), the Executive shall be entitled to: 

  
 4 

 (i) the Accrued Obligations; 

(ii) continued payment of the Executive’s then Base Salary, in accordance with the payroll practices of the Company, for a period equal to
eighteen (18) months (the “Severance Period”); 
 (iii) payment of the Executive’s Annual Bonus for the current
calendar year, pro- rated for the calendar year in which the Executive’s termination occurs based on actual results for such calendar year (determined by multiplying the amount of such bonus which would be due for the full calendar year by a
fraction, the numerator of which is the number of days during the calendar year of termination that the Executive is employed by the Company and the denominator of which is 365) payable at the same time bonuses for such year are paid to other
executives of the Company; and 
 (iv) subject to (A) the Executive’s timely election of continuation coverage under the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), (B) the Executive’s continued copayment of premiums at the same level and cost to the Executive as if the Executive were an employee of the Company
(excluding, for purposes of calculating cost, an employee’s ability to pay premiums with pre-tax dollars), and (C) the Executive’s continued compliance with the obligations in Sections 3(g) and 5 hereof, continued
participation in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan) which covers the Executive (and the Executive’s eligible dependents) for the duration of the Severance Period at the
Company’s expense, after taking into account Executive’s obligation under Section 3(d)(iv)(B) above, provided that the Executive is eligible and remains eligible for COBRA coverage; provided,
further, that the Company may modify the continuation coverage contemplated by this Section 3(d)(iv) to the extent reasonably necessary to avoid the imposition of any excise taxes on the Company for failure to comply
with the nondiscrimination requirements of the Patient Protection and Affordable Care Act of 2010, as amended, and/or the Health Care and Education Reconciliation Act of 2010, as amended (to the extent applicable) and provided, further, that in the
event that the Executive obtains other employment that offers group health benefits, the Company’s obligation to pay any portion of the cost of continuation of coverage under this Section 3(d)(iv) shall immediately cease.

 Following such termination of the Executive’s employment by the Company without Cause, except as set forth in this
Section 3(d), the Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(e) Termination by the Executive with Good Reason. The Executive may terminate the Executive’s employment with Good Reason by
providing the Company thirty (30) days written notice setting forth with reasonable specificity the event that constitutes Good Reason, which written notice, to be effective, must be provided to the Company within thirty (30) days of the
occurrence of such event or, if based on multiple events, the last of such events to occur. During such thirty (30) day notice period, the Company shall have a cure right (if curable), and if not cured within such period, the Executive’s
termination will be effective upon the date immediately following the expiration of the thirty (30) day notice period. In the event of the Executive’s termination for Good Reason, the Executive shall be entitled to the same payments and
other benefits as 

  
 5 

 
provided in Sections 3(d)(i) through (iv) above for a termination without Cause. Following such termination of the Executive’s employment by the Executive with Good
Reason, except as set forth in this Section 3(e), the Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

For purposes of this Agreement, “Good Reason” shall mean, without the Executive’s express written consent, the
occurrence of any of the following events: (i) a material diminution in the Executive’s responsibilities that is inconsistent with the Executive’s position as described herein; (ii) a material reduction by the Company in the
Executive’s Base Salary or Target Bonus; (iii) the office where Executive is currently working is moved more than fifty (50) miles from its current location: or (iv) the Company’s repeated or habitual breach of any other
material provision of this Agreement. 
 (f) Termination by the Executive without Good Reason. The Executive may terminate the
Executive’s employment without Good Reason at any time, by providing the Company thirty (30) days’ written notice of such termination. In the event of the termination of employment by Executive without Good Reason, the Executive shall
be entitled only to the Accrued Obligations other than the Prior Year’s Bonus. 
 Following such termination of employment without Good
Reason, except as set forth in this Section 3(f), the Executive shall have no further rights to any compensation or any other benefits under this Agreement. 

(g) Release. Notwithstanding any provision herein to the contrary, the payment of any and all amounts or provision of any and all
benefits pursuant to this Section 3 (other than the Accrued Obligations), shall only be payable if the Executive delivers to the Company and does not revoke a general release of claims in favor of the Company in a form
acceptable to the Company within twenty-one (21) days following receipt thereof from the Company, unless a longer review period is required by law and subject to continued compliance with Section 5 hereof (the
“Release”). Additionally, if the period during which the Release must be delivered and become irrevocable in accordance with this Agreement as a condition to the making hereunder of any “payment,” as such term is used in
Section III(C) of Internal Revenue Service Notice 2010-80, begins in one calendar year (the “earlier year”) and ends in the subsequent calendar year, then in no event shall such payment be made in the earlier year (and, if such
payment is delayed under this sentence to the subsequent year (and is otherwise required to be made under this Agreement), such payment shall be made as soon as administratively practicable in the subsequent year and the remaining payments shall
continue until the expiration of the Severance Period, subject to the provisions of this Agreement). 
 4. Compliance with
Section 409A. 
 (a) The intent of the Parties is that payments and benefits under this Agreement comply with Internal
Revenue Code Section 409A and the regulations and guidance promulgated thereunder (collectively, “Code Section 409A”) and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to
be in compliance therewith. To the extent that any provision hereof is modified in order to comply with Code Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the

  
 6 

 
original intent and economic benefit to the Executive and the Company of the applicable provision without violating the provisions of Code Section 409A. In no event whatsoever shall the
Company be liable for any additional tax, interest or penalty that may be imposed on the Executive by Code Section 409A or damages for failing to comply with Code Section 409A. 

(b) A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment
of any amounts or benefits upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement,
references to a “termination,” “termination of employment” or like terms shall mean “separation from service.” Notwithstanding anything to the contrary in this Agreement, if the Executive is deemed on the date of
termination to be a “specified employee” within the meaning of that term under Code Section 409A(a)(2)(B), then with regard to any payment or the provision of any benefit that is considered deferred compensation under Code
Section 409A payable on account of a “separation from service,” such payment or benefit shall not be made or provided until the date which is the earlier of (i) the expiration of the six (6)-month period measured from the date of
such “separation from service” of the Executive and (ii) the date of the Executive’s death, to the extent required under Code Section 409A. Upon the expiration of the foregoing delay period, all payments and benefits delayed
pursuant to this Section 4(b) (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid or reimbursed to the Executive in a lump sum with interest at the
prime rate as published in The Wall Street Journal on the first business day following the date of the “separation from service”, and any remaining payments and benefits due under this Agreement shall be paid or
provided in accordance with the normal payment dates specified for them herein. 
 (c) To the extent that reimbursements or other in-kind
benefits under this Agreement or otherwise constitute “nonqualified deferred compensation” for purposes of Code Section 409A, (i) all expenses or other reimbursements hereunder shall be made on or prior to the last day of the
taxable year following the taxable year in which such expenses were incurred by the Executive, (ii) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) no such
reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any
other taxable year. 
 (d) For purposes of Code Section 409A, the Executive’s right to receive any installment payments pursuant to
this Agreement shall be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment period with reference to a number of days, the actual date of payment within the specified
period shall be within the sole discretion of the Company. 
 (e) Notwithstanding any other provision of this Agreement to the contrary, in
no event shall any payment under this Agreement that constitutes “nonqualified deferred compensation” for purposes of Code Section 409A be subject to offset by any other amount unless otherwise permitted by Code Section 409A.

  
 7 

 5. Restrictive Covenants and Representations. 

(a) Confidential Information; Intellectual Property. 

(i) The Executive will not at any time, whether during or after the Term, (A) retain or use for the benefit, purposes or account of the
Executive or any other person; or (B) disclose, divulge, reveal, communicate, share, transfer or provide access to any person outside of the Company, it subsidiaries or its affiliates (other than Executive’s professional advisers who are
bound by confidentiality obligations or otherwise in performance of the Executive’s duties during the Executive’s employment and/or service with the Company and/or its affiliates and/or subsidiaries and pursuant to customary industry
practice), any non-public, proprietary or confidential information, including, without limitation, trade secrets, know-how, research and development, software, databases, inventions, processes, formulae, technology, designs and other intellectual
property, information concerning finances, investments, profits, pricing, costs, products, services, vendors, customers, clients, partners, investors, personnel, compensation, recruiting, training, advertising, sales, marketing, promotions,
government and regulatory activities and approvals, in each case, concerning the past, current or future business, activities and operations of the Company or any of its affiliates or subsidiaries and/or any third party that has disclosed or
provided any of same to the Company or any of its subsidiaries or affiliates on a confidential basis (“Confidential Information”), without the prior written authorization of the Board. 

(ii) ”Confidential Information” shall not include any information that is (A) generally known to the industry or the
public other than as a result of the Executive’s breach of this or any other confidentiality covenant; (B) made legitimately available to the Executive by a third party without breach of any confidentiality obligation of which the
Executive has knowledge; or (C) required by law to be disclosed; provided that with respect to subsection (C), the Executive shall give prompt written notice to the Company of such requirement, disclose no more information than is so required, and
reasonably cooperate with any attempts by the Company to obtain a protective order or similar treatment. 
 (iii) Except as required by law,
the Executive will not disclose to anyone, other than the Executive’s family (it being understood that, in this Section 5, the term “family” refers to the Executive, the Executive’s spouse, children,
parents and spouse’s parents) and advisors, the existence or contents of this Agreement; provided that Executive may disclose to any prospective future employer the provisions of this Section 5. This Section 5(a)(iii)
shall terminate if the Company publicly discloses a copy of this Agreement (or, if the Company publicly discloses summaries or excerpts of this Agreement, to the extent so disclosed). 

(iv) Upon termination of the Term for any or no reason, the Executive shall (A) cease and not thereafter commence use of any Confidential
Information or intellectual property (including without limitation, any patent, invention, copyright, trade secret, trademark, trade name, logo, domain name or other source indicator) owned or used by the Company or any of its subsidiaries; and
(B) immediately destroy, delete, or return to the Company, at the Company’s option, all originals and copies in any form or medium (including memoranda, books, papers, plans, computer files, letters and other data) in the Executive’s
possession or control (including any of the foregoing stored or located in the Executive’s office, home, laptop or other computer, whether or not Company property) that contain Confidential Information, except that the Executive may retain only
those portions of any personal notes, notebooks and diaries that do not contain any Confidential Information. 

  
 8 

 (v) 18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or
civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and
(ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this
Section 5 is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the Parties to this Agreement have the right to disclose
in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The Parties also have the right to disclose trade secrets in a
document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure. 
 (b) Non-Competition/Non-Solicitation. 
 (i) While Executive is
employed by the Company or any of its Affiliates and during the 12 month period immediately following the date of the cessation of Executive’s employment (the employment and post-employment periods, in the aggregate, the “Restricted
Period”), Executive agrees to not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, in any capacity similar or related to the capacity in which Executive has been employed
by the Company or any of its Affiliates, compete with the Company or any of its Affiliates (A) in any geographic area in which the Company or any of its Affiliates does business during Executive’s employment or (B) within twenty five
(25) miles of any location where the Company or any of its Affiliates has one or more clients or customers during Executive’s employment or, with respect to the portion of the Restricted Period that follows the termination of
Executive’s employment, at the time of such termination (the “Restricted Area”). Specifically, but without limiting the foregoing, Executive agrees not to work or provide services, in any capacity similar or related to the
capacity in which Executive has been employed by the Company or any of its Affiliates, anywhere in the Restricted Area, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any Person that is engaged,
in whole or in part, in the Business, including, but not limited to, naviHealth, Archway Health, PatientPing, Unite Us and Matrix Medical Network. 

(ii) “Business” means any business that (i) provides home health assessments or care management services to patients in
the home; (ii) provides complex care management services in skilled nursing facilities or other post-acute facilities; or (iii) any other business in which the Company or any of its Affiliates is engaged in during Executive’s
employment, or, with respect to the portion of the Restricted Period that follows termination of Executive’s employment, at the time of such termination. 

  
 9 

 (c) Intellectual Property. 

(i) If the Executive creates, invents, designs, develops, contributes to or improves any works of authorship, inventions, intellectual
property, materials, documents or other work product (including without limitation, research, reports, software, databases, systems, applications, presentations, textual works, content, or audiovisual materials) (“Works”), either
alone or with one or more third parties, at any time during the Executive’s Term and within the scope of such employment and/or service with the use of any resources of the Company or its subsidiaries (collectively, “Company
Works”), the Executive shall promptly and fully disclose same to the Company and hereby irrevocably assigns, transfers and conveys, to the maximum extent permitted by applicable law, all of the Executive’s right, title, and interest
therein (including rights under patent, industrial property, copyright, trademark, trade secret, unfair competition, other intellectual property laws, and related laws) to the Company to the extent ownership of any such rights does not vest
originally in the Company. If the Executive creates any written records (in the form of notes, sketches, drawings, or any other tangible form or media) of any Company Works, the Executive will keep and maintain same. The records will be available to
and remain the sole property and intellectual property of the Company at all times. 
 (ii) The Executive shall take all requested actions
and execute all requested documents (including any licenses or assignments required by a government contract) at the Company’s expense (but without further remuneration) to assist the Company in validating, maintaining, protecting, enforcing,
perfecting, recording, patenting or registering any of the Company’s rights in the Company Works. 
 (iii) The Executive shall not
improperly use for the benefit of, bring to any premises of, divulge, disclose, communicate, reveal, transfer or provide access to, or share with the Company or its subsidiaries any confidential, proprietary or non-public information or intellectual
property relating to a former employer or other third party without the prior written permission of such third party. The Executive shall comply with all relevant policies and guidelines of the Company and its subsidiaries that are from time to time
previously disclosed to the Executive, including regarding the protection of Confidential Information and intellectual property and potential conflicts of interest. 

(iv) The provisions of Section 5(c) hereof shall survive the termination of the Executive’s Term for any or no
reason. 
 (d) Whistleblower Protection. Notwithstanding anything to the contrary contained in this Agreement (including
Section 5), no provision of this Agreement shall be interpreted so as to impede the Executive (or any other individual) from reporting possible violations of federal law or regulation to any governmental agency or entity,
including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or making other disclosures under the whistleblower provisions of federal law or regulation. The
Executive does not need the prior authorization of the Company or its subsidiaries to make any such reports or disclosures, and the Executive shall not be required to notify the Company or its subsidiaries that such reports or disclosures have been
made. 
 (e) Blue Pencil. It is the desire and intent of the Parties that the provisions of this Section 5 shall be enforced to
the fullest extent permissible under the laws and policies in the jurisdiction in which enforcement is sought. Accordingly, if any particular provision or clause of this Section 5 shall be adjudicated to be invalid or
unenforceable, then such provision or clause shall be deemed amended to delete therefrom the portion thus adjudicated to be invalid or unenforceable. 

  
 10 

 (f) Equitable Relief and Other Remedies. The Executive acknowledges and agrees that
the Company’s remedies at law for a breach or threatened breach of any of the provisions of Section 5 of this Agreement would be inadequate and, in recognition of this fact, the Executive agrees that, in the event of such a breach or
threatened breach, in addition to any remedies at law, the Company, without posting any bond or other security, shall be entitled to obtain equitable relief in the form of specific performance, a temporary restraining order, a temporary or permanent
injunction or any other equitable remedy which may then be available, without the necessity of showing actual monetary damages. In the event of a violation by the Executive of Section 5 of this Agreement hereof as determined by the Company in
good faith, any severance being paid to the Executive pursuant to this Agreement or otherwise shall immediately cease, and any severance previously paid to the Executive shall be immediately repaid to the Company. 

(g) Return of Property. Upon termination of the Executive’s employment with the Company for any reason whatsoever, voluntarily or
involuntarily (and in all events within five (5) days of the Executive’s date of termination), and at any earlier time the Company requests, the Executive will deliver to the person designated by the Company all originals and copies of all
documents and property of the Company in the Executive’s possession, under the Executive’s control or to which the Executive may have access, including but not limited to, any office or communications equipment (e.g., laptop, cellular
phone, etc.) that the Executive has or has been using, and any business or business-related files that the Executive has in the Executive’s possession. The Executive will not reproduce or appropriate for the Executive’s own use, or for the
use of others, any property or Confidential Information, and shall remove from any personal computing or communications equipment all information relating to the Company. 

(h) Non-Disparagement. The Executive agrees that the Executive will not disparage the Company,
its subsidiaries and parents, and their respective the Executives, directors, investors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and administrators, or make any public statement reflecting
negatively on the Company, its subsidiaries and parents, and their respective officers, directors, investors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and administrators, to third parties,
including, but not limited to, any matters relating to the operation or management of the Company, irrespective of the truthfulness or falsity of such statement. The Board agrees not to (and shall instruct the Company’s executive officers not
to), directly or indirectly, disparage the Executive in any manner that is likely to be harmful to the Executive’s business reputation. The foregoing limitation on either Party shall not be violated by truthful statements in response to legal
process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings), and the foregoing limitation on the Company’s executives and
directors shall not be violated by statements that they in good faith believe are necessary or appropriate to make in connection with performing their duties and obligations to the Company. 

(i) Cooperation. During the Term and thereafter, the Executive shall cooperate with the Company and its parents, subsidiaries and
affiliates, upon the Company’s reasonable request, with respect to any internal investigation or administrative, regulatory or judicial proceeding involving matters within the scope of the Executive’s duties and responsibilities to the
Company 

  
 11 

 
(including, without limitation, the Executive being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company’s reasonable request
to give testimony without requiring service of a subpoena or other legal process, and turning over to the Company all relevant Company documents which are or may come into the Executive’s possession during the Term) (collectively, the
“Claims”). The Executive agrees to promptly inform the Company if the Executive becomes aware of any lawsuits involving Claims that may be filed or threatened against the Company or any of its affiliates. The Executive also agrees
to promptly inform the Company (to the extent that the Executive is legally permitted to do so) if the Executive is asked to assist in any investigation of the Company or its affiliates (or their actions) or another party attempts to obtain
information or documents from the Executive (other than in connection with any litigation or other proceeding in which the Executive is a party-in-opposition) with respect to matters the Executive believes in good faith to relate to any
investigation of the Company or its affiliates, in each case, regardless of whether a lawsuit or other proceeding has then been filed against the Company or any of its affiliates with respect to such investigation, and shall not do so unless legally
required. During the pendency of any litigation or other proceeding involving Claims, the Executive shall not communicate with anyone (other than the Executive’s attorneys and tax and/or financial advisors and except to the extent that the
Executive determines in good faith is necessary in connection with the performance of the Executive’s duties hereunder) with respect to the facts or subject matter of any pending or potential litigation or regulatory or administrative
proceeding involving the Company or any of its affiliates without giving prior written notice to the Company or the Company’s counsel. Upon presentation of appropriate documentation, the Company shall pay or reimburse the Executive for all
reasonable out-of-pocket travel, reasonable attorney fees, duplicating or telephonic expenses incurred by the Executive in complying with this Section 5(i). Company shall also indemnify and
hold Executive harmless for any claims, lawsuits, judgments and damages, in accordance with Section 7.7 of the Second Amended and Restated Limited Liability Company Agreement of Cure Topco, LLC dated November 27, 2019. 

(j) Executive Representation. The Executive represents and warrants to the Company that there are no restrictions, agreements or
understandings whatsoever to which the Executive is a party which would prevent or make unlawful the Executive’s execution of this Agreement or the Executive’s employment hereunder, which is or would be inconsistent or in conflict with
this Agreement or the Executive’s employment hereunder, or would prevent, limit or impair in any way the performance by the Executive of the obligations hereunder. In addition, the Executive has disclosed to the Company all restraints,
confidentiality commitments and other employment restrictions that the Executive has with any other employer, person or entity. The Executive covenants that in connection with the Executive’s provision of services to the Company and its
subsidiaries, the Executive shall not breach any obligation (legal, statutory, contractual or otherwise) to any former employer or other person, including, but not limited to, obligations relating to confidentiality and proprietary rights. 

(k) Tolling. In the event of any violation of the provisions of this Section 5, the Executive acknowledges and agrees that the
post-termination restrictions contained in this Section 5 shall be extended by a period of time equal to the period of such violation, it being the intention of the Parties hereto that the running of the applicable post-termination restriction
period shall be tolled during any period of such violation. 

  
 12 

 6. Survival. The respective rights and obligations of the Parties under this Agreement shall survive
any termination of the Executive’s employment to the extent necessary to the intended preservation of such rights and obligations. 
 7.
Assignment. This Agreement may be assigned, without the consent of the Executive, by the Company to any person, partnership, corporation or other entity that has purchased all or substantially all of the assets of the Company, provided such
assignee assumes any and all of the liabilities of the Company hereunder. The duties and responsibilities of the Executive under this Agreement are of a personal nature and shall not be assignable or delegable in whole or in part by the Executive.
The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business or assets of the Company to expressly assume and agree to perform this
Agreement in the same manner and to the same extent as the Company would be required to perform if no such succession had taken place. 
 8. Entire
Agreement. This Agreement, together with the separate Incentive Award Agreement, sets forth the entire understanding between the Parties hereto with respect to the subject matter hereof and cannot be changed, modified, extended or terminated
except upon written amendment approved by the Company and by the Executive. This Agreement supersedes and replaces any and all prior employment or other agreements between the Executive and the Company or any of its subsidiaries that relate to any
matter that is also the subject of this Agreement; provided, however, that nothing herein will supersede, amend or replace any of the terms of the Support and Restrictive Covenant Agreement. 

9. Remedies Cumulative; No Waiver. No remedy conferred upon a Party by this Agreement is intended to be exclusive of any other remedy, and each and
every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement or now or hereafter existing at law or in equity. No delay or omission by a Party in exercising any right, remedy or power under this
Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such Party from time to time and as often as may be deemed expedient or necessary by such Party in its sole
discretion. 
 10. Beneficiaries/References. The Executive shall be entitled, to the extent permitted under any applicable law, to select and change a
beneficiary or beneficiaries to receive any compensation or benefit payable under this Agreement following the Executive’s death by giving the Employer written notice thereof. In the event of the Executive’s death or a judicial
determination of the Executive’s incompetence, reference in this Agreement to the Executive shall be deemed, where appropriate, to refer to the Executive’s beneficiary, estate or other legal representative. 

11. Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall withhold from any payments
under this Agreement all federal, state and local taxes as the Company is required to withhold pursuant to any law or governmental rule or regulation. The Executive shall bear all expense of, and be solely responsible for, all federal, state and
local taxes due with respect to any payment received under this Agreement. 

  
 13 

 12. Notices. All notices, consents, waivers and other communications under this Agreement must be in
writing and will be deemed to have been duly given when (i) delivered by hand (with written confirmation of receipt), (ii) received by the addressee, if sent by certified mail, return receipt requested, or (iii) received by the addressee,
if sent by a nationally recognized overnight delivery service, return receipt requested, in the case of Executive, to the home address as reflected on the records of the Company, and in the case of the Company, to the address set forth below (or in
either case to such other addresses as a Party may designate by notice to the other Party): 
 If to the Company, to: 

Cure TopCo, LLC 

c/o Signify Health 

800 Connecticut Avenue 

Norwalk, CT 06854 

Attn: Chief Executive Officer 

13. Governing Law and Waiver of Jury Trial. 

(a) This Agreement shall be governed by, and construed in accordance with, the laws of the State of Texas, without giving effect to any choice
of law or conflict of law rules or provisions (whether of the State of Texas or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Texas. Each of the Parties hereto hereby waives, to the
fullest extent permitted by law, any right to trial by jury of any claim, demand, action, or cause of action (i) arising under this Agreement or (ii) in any way connected with or related or incidental to the dealings of the Parties hereto
in respect of this Agreement. The Parties hereto each hereby agrees and consents that any such claim, demand, action, or cause of action shall be decided by court trial without a jury and that the Parties hereto may file an original counterpart of a
copy of this Agreement with any court as written evidence of the consent of the Parties hereto to the waiver of their right to trial by jury. Any legal proceeding to enforce the terms of this Agreement, shall be filed exclusively in the District
Court located in Dallas, Texas. 
 (b) The Executive (i) agrees that service of process in any such any claim, demand, action,
proceeding or cause of action arising under this Agreement may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such Party, in the case of the Executive,
at the Executive’s address shown in the books and records of the Company or, in the case of the Company, at the Company’s principal offices, attention General Counsel and (ii) agrees that nothing in this Agreement shall affect the
right to effect service of process in any other manner permitted by the laws of the State of Texas. 
 14. Counterparts. This Agreement may be
executed in counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument. 

15. Headings. The headings of sections and subsections herein are included solely for convenience of reference and shall not control the meaning or
interpretation of any of the provisions of this Agreement. 

  
 14 

 16. Severability. If any provision of this Agreement or application thereof to anyone or under any
circumstances is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given effect without the invalid or unenforceable
provision or application and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to particular circumstances, it shall
nevertheless remain in full force and effect in all other circumstances. 
 17. Prevailing Party Costs and Attorneys’ Fees. In the event it
becomes necessary for any party hereto to engage in any litigation to enforce the terms and conditions of this Agreement, the prevailing party shall be entitled to recover all court costs, reasonable attorneys’ fees, and other litigation
expenses incurred it in enforcing this Agreement. 
 [Signature Pages Follow] 

  
 15 

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the day
and year first above written. 
  

			
	 CURE TOPCO, LLC

		
	By:	 	 /s/ Steve Senneff

	Name: Steve Senneff
	 Title: President & CFO

  

	
	 EXECUTIVE

	
	 /s/ David Pierre

	 Name: David Pierre

	 Title: Chief Operating Officer

  
 [Signature Page to
Employment Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]